Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Cancer|December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genesPetros Grivas, Amir Mortazavi, Joel Picus, et al.Journal for Immunotherapy of Cancer|March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter studyNieves Martinez Chanza, Wanling Xie, Majd Issa, et al.Clinical Genitourinary Cancer|May 30, 2026
Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing SchedulesMichal Sternschuss, Charlie White, Colleen Quinlan, et al.Leukemia & Lymphoma|March 9, 2017
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomasDouglas W Sborov, Alessandro Canella, Erinn M Hade, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.JCI Insight|March 9, 2026
Determinants of pancreatic tropism in metastatic renal cell carcinomaHaitao Xu, Payal Kapur, Alana Christie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancerToni K Choueiri, Robert W Ross, Susanna Jacobus, et al.Oncotarget|November 5, 2017
Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancerMichele R Wing, Julie W Reeser, Amy M Smith, et al.Cancer|August 7, 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancerTian Zhang, Michael R Harrison, Peter H O'Donnell, et al.Pageof 9